Orthofix Medical Inc.

OFIXNASDAQHealthcare● Active

$9.69

$-0.60(-5.83%)

Market Cap$391685808

P/E Ratio—

52W High$16.99

52W Low$9.13

Avg Volume350K

Open$10.25

Beta0.71

Free Cash Flow Financials Revenue

Orthofix Medical Inc. (OFIX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

OFIX · free cash flow · updated Jun 8, 2026

Core FCF metrics

OFIX · FCF · TTM · margin & CAGR

Free cash flow was −$1.3M for FY2025 (fiscal year ending 2025-12-31), up 85.9% year-over-year The FCF margin was -0.2%.

FY2025 Free Cash Flow−$1.3M▲ +85.9% YoY

Trailing 12M (TTM)−$3.6Mtrailing 4 quarters sum

FCF Margin-0.2%−$1.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

OFIX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$33.3M(35M)−$1.3M▲ +85.9%-0.2%

FY2024$25.8M(35M)−$9.1M▲ +91.6%-1.1%

FY2023−$45.8M(62M)−$107.8M▼ 210.7%-14.4%

FY2022−$11.5M(23M)−$34.7M▼ 3006.4%-7.5%

FY2021$18.5M(20M)−$1.1M▼ 102.0%-0.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

OFIX · P/FCF · FCF yield · FCF per share

Orthofix Medical Inc. (OFIX) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

OFIX · cash flow statement · operating / investing / financing

For FY2025, Orthofix Medical Inc. generated $33.3M in operating cash flow and spent 35M in capital expenditures, yielding −$1.3M in free cash flow.

Operating Activities

+$33.3M

Cash from core business operations

2025-12-31

Investing Activities

−$34.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$0.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($33.3M) − |CapEx| (35M) = FCF (−$1.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

OFIX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Orthofix Medical Inc.YOU

OFIX

−$1.3M+85.9%-0.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Orthofix Medical Inc. (OFIX) reported free cash flow of −$1.3M for FY2025 (fiscal year ending 2025-12-31), up 85.9% year-over-year. The FCF margin was -0.2%.

Based on available data, Orthofix Medical Inc. has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $57.2M in FY2020.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

OFIX free cash flow · 8 questions

Orthofix Medical Inc. free cash flow was −$1.3M for FY2025, up 85.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$3.6M.

OFIX free cash flowOFIX FCFOFIX FCF 2025OFIX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Orthofix Medical Inc. · Orthofix Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026